Very happy to announce that Tridek One closes a new financing round with an international VC syndicate to develop first in class immune checkpoint agonists. AdBio was co-founder and the first investor on board, quickly joined by Advent Life Sciences. Read the Press Release
Acticor Biotech winner of the Prix Galien Medstartup in the category “BEST COLLABORATION IN THE PHARMACEUTICAL OR BIOTECHNOLOGICAL INDUSTRY”,organized by the prestigious Galien Foundation and by Business France. Read the press release Acticor Biotech announces FDA acceptance of its IND Application for Glenzocimab in Acute Ischemic Stroke Read the press release
If you don’t know the YouTube channel of Dr IZA, this is the perfect occasion to discover it: a new great video has just been published by Ilyass Zouhry (alias Dr IZA): Ilyass is a young and talented pathologist . He is currently a PhD fellow in our research unit (Team 1). You can also follow him on his… Read more »
The winner of this prize is chosen by the donors of the Fondation de l’Avenir from among six high-quality projects. The team of Professor Mikael MAZIGHI (Team 6), neurologist, Adolphe de Rothschild Foundation Hospital in Paris, was chosen for its work on how to advance the treatment of stroke. This Trophy was presented by Serge BRICHET, President Mutualité function publique… Read more »
Prof. Marianne Abi Fadel, Dean of the Faculty of Pharmacy at USJ and member of the UMRS1148 Team 2, received the Christophe Mérieux 2021 Prize from the Fondation Christophe et Rodolphe Mérieux- Institut de France. This prize, which will be awarded on June 2, 2021 to the Institut de France, will be mainly dedicated to research projects and humanitarian projects… Read more »
L’OPECST a mis en ligne ce jour un rapport sur l’intégrité scientifique de 134 pages. Ci-jointe, la synthèse de 4 pages avec les 10 recommandations: 2021_Synthèse Intégrité scientifique_FR
We are proud to announce that Anne Pellé (Team 3) has been promoted and appointed in the “ordre national de la légion d’honneur au grade de chevalier”. Congratulation to her!!
– Approval of phase 2 GARDEN study in France and Brazil – GARDEN will enroll 60 patients hospitalized for COVID19 – First Patient included at University Hospital of Strasbourg Acticor Biotech is a clinical stage biotechnology spin-off of INSERM (built upon the expertise and the results of research conducted by the founders: Dr. Martine Jandrot-Perrus from U1148 Team 6 and Pr…. Read more »
Each year,the Fondation Bettencourt awards prizes for Postdoc training to young investigators. Among the 14 laureates of the 2020 edition, Karen Aymonnier (ex-Team 6 PhD student) received one of the prizes for a project that will be conducted in the Denisa Wagner lab. She will continue to work on the interaction of neutrophils and platelets during thrombosis.
Our research unit is spotlighted in the last issue of the European Heart Journal. Read the full paper: pdf
As part of its policy of supporting medical research, the City of Paris annually awards two Grand Prizes to eminent personalities from the Parisian scientific community. Meeting on January 28, 2020, the jury for the Grands Prix de Médecine chose its winners: Philippe-Gabriel Steg (Team 5) and Nicolas Manel. The Grand Prix of Medicine and Medical Research of the City… Read more »
In issue 44 of the INSERM journal, an article is devoted to the Tridek-one startup whose 2 scientific co-founders are Giuseppina CALIGIURI and Antonino NICOLETTI who lead Team 1. Read the Article.
Giuseppina Caligiuri (Team 1) and Danilo Norata (University of Milan) present the content of a Cardiovascular Research spotlight issue focusing on immunometabolism. Link to issue. Aim of this Spotlight Issue is to present an overview of how changes in metabolic pathways of immune cells impact their function in the context of cardiovascular and metabolic diseases. Moreover, classical risk factors affect… Read more »
The ISTH honored Martine Jandrot-Perrus (Team 6) amongst four other members with the Esteemed Career Award at the ISTH 2019 Congress Opening Ceremony. These awards are presented annually to individuals whose career contributions have significantly advanced the scientific community’s understanding of diseases and disorders that affect hemostasis. Their accomplishments are internationally regarded as exemplary models of research and mentoring excellence…. Read more »
Le décret, en date du 20 mars 2019, portant création de l’Université de Paris est paru au Journal officiel de la République française. En savoir plus
Prof. Philippe Gabriel Steg (head of Team 5) has been appointed “Vice President for Research” of the Executive Board of the AP-HP on joint proposal of deans, university presidents and Inserm. The Management Board is chaired by the Director General and has two other vice presidents: the president of the medical commission of establishment of the AP-HP, Prof. Christmas Garabedian, is… Read more »
In the last issue of the Magazine Science&Santé of INSERM, there is a portrait of Catherine Boileau (co-head of Team 2) where her career is called to mind. Read the dossier
Jean-Baptiste Michel (Team 2) received the MATMUT prize for Medical Innovation 2018. Read more on the Fondation de l’Avenir web site
Catherine BOILEAU (Team 2) was awarded, together with Helen Hobbs (University of Texas Southwestern Medical School, Dallas – Etats-Unis) and Nabil Seidah (Institut de recherches cliniques de Montréal – Canada), the Grand Prix de la Fondation Lefoulon Delalande during a ceremony held on Wednesday, May 30 2018 under the Dome of the Institut de France. The ceremony was chaired by Mr…. Read more »